Crowdonomics
This isn’t CANCERVAX’s most recent raise. Reg CF · Common Stock · Jun 2026 (Open) is more current.View latest round
CANCERVAX

Reg A+ · Equity · Mar 2024

OpenReg A+Equity
via DALMORE GROUP LLC · last checked Aug 16, 2026
Raised
$38.2K / $5M max
1% of ceiling
Investors
—
—
Momentum
$41/day
—

Financials disclosed in this offering

FY2022 · hover for source
$0
−$690K
FY2022
RevenueNet income
Metric
FY2022 audited
Income statement
Revenue
$0
Cost of goods sold
-$636,086
Net income
-$689,624
Balance sheet
Cash
$602,748
Accounts receivable
$0
Total assets
$624,039
Long-term debt
$2,000,000
Total liabilities
$11,890
Other
Headcount
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Mar 11, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Feb 14, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Price / share$2.10
Shares offered3,095,239

Down round. Priced 98% below Private Offering (2023) (Oct 2023): $2.10 vs $100.00 a share in today's terms.

Offering details

Target—
Max$5,000,000
Min investment—
OpenedMar 22, 2024
Deadline—
Days active931

Links & provenance

Source: SEC EDGAR
0001493152-23-044240
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.